Findings

What do systematic reviews say?

30 questions · 31 findings · 6 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 16.1%GRADE not reported 6 · 19.4%Very low 9 · 29%Low 4 · 12.9%Moderate 4 · 12.9%High 3 · 9.7%

Standardised formal neonatal resuscitation training (SFNRT) programme with boosters vs SFNRT

Skills retention ‐ any booster on performance scores · healthcare professionals involved in attending deliveries

It is very uncertain whether standardised formal neonatal resuscitation training (SFNRT)… changes skills retention ‐ any booster on performance scores compared with SFNRT (very low certainty).

1 finding from 1 review

Standardised formal resuscitation training programmes for reducing mortality and morbidity in newborn infants 2015 · Cochrane Headline outcomes only
MD 5.48
1 study · 44 participants
Very low

A boost of inhaled corticosteroids vs usual care

Exacerbations · autumn asthma exacerbations in children

A boost of inhaled corticosteroids showed no clear difference in exacerbations compared with usual care (moderate certainty).

1 finding from 1 review

Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
OR 0.86 [0.32, 2.3]
1 study · 173 participants
Moderate

A boost of inhaled corticosteroids vs usual care

Adverse events · autumn asthma exacerbations in children

A boost of inhaled corticosteroids showed no clear difference in adverse events compared with usual care (moderate certainty).

1 finding from 1 review

Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
OR 0.67 [0.34, 1.33]
1 study · 176 participants
Moderate

Accelerated radiotherapy with concomitant boost vs Conventional (standard) fractionation radiotherapy

Locoregional control · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy 2010 · Cochrane All outcomes
Accelerated/boost vs conventional, locoregional control: IPD from one trial (Fu 2000); a statistically significant difference in favour of the accelerated schedule with boost was shown (Analysis 1.2). No numeric…
1 study
GRADE not reported

Accelerated radiotherapy with concomitant boost vs Conventional (standard) fractionation radiotherapy

Total mortality · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…

Accelerated radiotherapy with concomitant boost showed no clear difference in total mortality compared with conventional (standard) fractionation radiotherapy; GRADE not reported.

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy 2010 · Cochrane All outcomes
HR 0.95 [0.80, 1.13]
3 studies · 1203 participants
GRADE not reported

Accelerated radiotherapy with concomitant boost vs Conventional (standard) fractionation radiotherapy

Disease-free survival · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy 2010 · Cochrane All outcomes
Accelerated/boost vs conventional, disease free survival: all four trials provided data; pooled estimate showed a statistically significant difference in favour of the accelerated/boost schedule, with statistical…
4 studies · 1203 participants
GRADE not reported

WC‐rBS vaccine (Dukoral): two doses ± booster dose vs placebo

Cases of cholera ( · healthy children and adults; high risk population

1 finding from 1 review

Oral killed cholera vaccines for preventing cholera 2024 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 16423 participants
High

Accelerated radiotherapy (no split, boost or hyperfractionation) vs Conventional (standard) fractionation radiotherapy

Total mortality · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy 2010 · Cochrane All outcomes
Accelerated vs conventional, total mortality: only one trial reported data (Skladowski 2006; IPD available). A statistically significant difference in favour of the altered fractionation was shown (Analysis 1.1). No…
1 study
GRADE not reported

Accelerated radiotherapy (no split, boost or hyperfractionation) vs Conventional (standard) fractionation radiotherapy

Locoregional control · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy 2010 · Cochrane All outcomes
Accelerated vs conventional, locoregional control: one trial (Skladowski 2006); a statistically significant difference in favour of the altered fractionation was shown (Analysis 1.2). No numeric estimate given.
1 study
GRADE not reported

Accelerated radiotherapy (no split, boost or hyperfractionation) vs Conventional (standard) fractionation radiotherapy

Disease-free survival · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy 2010 · Cochrane All outcomes
Accelerated vs conventional, disease free survival: both trials reported this, but substantial clinical and statistical heterogeneity (P = 0.0004, I2 = 92%) meant a pooled analysis was not reported (Analysis 1.3).
2 studies
GRADE not reported